Diabetes, insulin resistance, hypertension, weight gain and increasing alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are known risk factors for disease progression from NASH to liver fibrosis [4]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.